More talk must equal more action – ADHD, stigma & medication

July 4, 2022 | Research | ADHD, ADHD News, Expert Insight

The mental health awareness movement is making an impact online – ADHD is no exception. Many of you reading this will most likely have stumbled across more people (across all media) opening up about their experiences with mental health. Or, you might have come across hashtags on social media and messages such as #itsokaynottobeokay. Although the thinking behind the phrase is well-intentioned, ‘people should be comfortable in speaking up when they’re not okay’, it raises some debate. For example, while it is positive that people talk about their challenges, is it really okay to not be okay for an extended time?

Rebecca Lawrence of The Guardian makes this point: “There are many well-meaning campaigns that encourage disclosure of illness; the problem is that they’re not always followed up by the resources necessary to actually help people” [1]. The question then is, do we need to see a shift in the message? In his podcast, Life Lessons from Sport and Beyond, Simon Mundie and Clinical Psychologist Dr. Amy Izycky discuss how we might adapt “the narrative around mental health from ‘It’s okay not to be okay’ – true of course – to ‘It’s okay to do the work to be ok” [2].

With many mental health and neurodevelopmental conditions, the ‘work to be okay’ is multifactorial, and the best approach for ADHD specifically, according to the literature, is a combination of medication and behavioral intervention [3]. Similar to other conditions, there is still a stigma around medication. The #PostYourPill campaign led by Dr. Alex George, Youth Mental Health Ambassador for The Department for Education, led to an outpouring of social media posts of people sharing the medication they take for various mental health conditions and explaining why they take them [4]. This has unquestionably had a positive impact on challenging the negative stereotypes related to people taking medication to support their mental health. Among the social media posts were many sharing their use of medication for ADHD – again sharing an important message that, for some people, medication has a real impact on their symptoms.

This campaign also touches on something important – treatment compliance. Adherence to treatment among those with ADHD is low, perhaps, in part, due to the fact that a common symptom is forgetfulness [5]. Moreover, there is often some reluctance to take medication given the stigma and misinformation around stimulant medication. Take the example of the online media publication Vice comparing Adderall to methamphetamine – a commonly pedaled and incredibly unhelpful analogy with one being a prescribed, FDA-cleared, treatment and the other being an uncontrolled and highly illegal street drug [6].

It is worth highlighting that ADHD is a debilitating disorder that in many cases continues into adulthood which impacts many aspects of someone’s life and these change as individuals get older (7) (Figure 1.)

More talk must equal more action - ADHD, stigma & medication diagram

Figure 1. Stages of ADHD. V A Harpin, 2005 (Adapted from Kewley G, 1999) [7]

Treatment adherence is just one of the many challenges in ADHD care, and still, many patients who live undiagnosed with – and untreated ADHD can influence some of the wide-ranging challenges as listed in Figure 1 above. In the UK, for example, there are many people with undiagnosed ADHD – especially girls and women. We see this in research showing rates of diagnosis reach gender parity by adulthood – meaning many of those girls were not given support and treatment during important developmental periods [8]. This can lead to complications in profiles with other comorbidities and mental health problems, many of which have been highlighted in the recent discussions around mental health including anxiety and depression, as two examples [9].

Many people go through their life thinking there is something wrong with them, have very low self-esteem, knowing something is different, and do not know why. For many people, a diagnosis was the last piece of the puzzle, the start to finally understand themselves, the start of their journey towards identity. When people do receive a diagnosis, many are left feeling ‘so what now?’. Many start developing coping mechanisms and learning how to manage their ADHD. Some do lots of research and find that connecting with others (online and offline) who also have ADHD helps, finding out that all those traits you thought were individual to you, or picked on for, are shared by thousands of others.

This leads directly back to the fundamental point we’re making here. Is awareness and the shared experience enough? For some, it might be, depending on the environment you’re in, the work you have, and the demands of life. ADHD certainly doesn’t prevent you from succeeding educationally or vocationally, but for many people, ADHD can put a significant strain on many aspects of their life and research shows that treatment is the best course of action in these cases. Research shows children with a diagnosis of ADHD that are treated have better educational outcomes than children with just a diagnosis of ADHD [10]. Additionally, research featured in The Archives of Pediatrics & Adolescent Medicine shows that there is no benefit, in fact possibly inducing worse long-term outcomes, in identifying children with ADHD without then providing them with extra support and treatment (11). The researchers suggest this may reflect the adverse effects of labelling, i.e., children may be treated differently after having received an ADHD ‘label’ at a young age. This raises several problems, but most concerning is that children not only have to deal with difficult ADHD symptoms but may also suffer the consequences of the stigma and shame surrounding ADHD.

There is no shortage of evidence showing how un-managed/un-diagnosed ADHD can severely impact the individual, their family, and society – showing how important a joint effort to identify and support a child with ADHD is. Ultimately, it is so important that we are having frank conversations about ADHD and mental health as a whole, and for the best results, it must be followed by action, both from providers and patients. For ADHD specifically, we must find ways to support those who want to act, specifically targeting the stigmas (which sadly still exist) and adherence; making the most of technology to help patients get to their appointments and take their medication if prescribed. Getting an objective look at symptoms and how they can improve with medication is also paramount to increasing patient understanding of their symptoms, and how medication may help.


[1] Lawrence, R. (2021, April 28). ‘It’s OK to not be OK’ is a nice hashtag, but does it really help? The Guardian.

[2] Mundie, S. (Host). 2021, 25th October. Challenging the Champion Narrative: Dr Amy Izycky. [Audio Podcast Episode]. In LIFE LESSONS: FROM SPORT AND BEYOND. Mundie Mundial Limited.

[3] National Institute for Health and Care Excellence. (2018, March). Attention deficit hyperactivity disorder (update) [F] Evidence review for combined pharmacological and non-pharmacological treatments review (NICE guideline NG87). NICE. From

[4] Lewis-Bungay, T. (2021, December 8). The #PostYourPill Trend: What Is It? Glamour UK.

(5) National Institute for Health and Care Excellence. (2018, March). Attention deficit hyperactivity disorder (update) [G] Evidence reviews for Adherence to treatment (pharmacological and non-pharmacological) (NICE guideline NG87). NICE. from

[6] Hart, C. L. (2016, February 9). A Neuroscientist Explains How He Found Out Meth Is Almost Identical to Adderall. Vice. Retrieved December 15, 2021, from

[7] Harpin, V. A. (2005). The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Archives of Disease in Childhood, 90(suppl_1), i2–i7.

[8] McCarthy, S., Wilton, L., Murray, M. L., Hodgkins, P., Asherson, P., & Wong, I. C. (2012). The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatrics, 12(1).

[9] Quinn, P.O. Attention-deficit/hyperactivity disorder and its comorbidities in women and girls: An evolving picture. Curr Psychiatry Rep 10, 419–423 (2008).

[10] Scheffler RM, Brown TT, Fulton BD, Hinshaw SP, Levine P, Stone S. Positive association between attention-deficit/ hyperactivity disorder medication use and academic achievement during elementary school. Pediatrics. 2009 May;123(5):1273-9. doi: 10.1542/peds.2008-1597. PMID: 19403491

[11] Sayal K, Owen V, White K, Merrell C, Tymms P, Taylor E. Impact of Early School-Based Screening and Intervention Programs for ADHD on Children’s Outcomes and Access to Services: Follow-up of a School-Based Trial at Age 10 Years. Arch Pediatr Adolesc Med. 2010;164(5):462–469. doi:10.1001/archpediatrics.2010.40

Related Blogs

01 Jun

Evaluating ADHD in primary care – objectively

1-minute summary: This case study shares the story of how the Sunlight Group Practice in the Wirral, Merseyside, is the...
19 May

ADHD: What’s behind the recent explosion in diagnoses?

Discover New Scientist’s latest article on QbTest and how objective tests are helping patients receive ADHD diagnosis and the right...
05 Apr

Living with ADHD and the importance of early diagnosis

Kent Surrey and Sussex Academic Health Science Network (KSSAHSN), a part of the wider Academic Health Science Network (AHSN) have...